Concepedia

Gael McWalter

GM

Statistics

Publications

8

Citations

1.1K

H-Index

8

Active since

2009

Affiliations

AstraZeneca (United Kingdom)(Current)

Gael McWalter is an author at AstraZeneca (United Kingdom) specializing in oncology, medicine, and molecular oncology.

Publications per year

2009–2015

8

Publications

8

Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status

Jean‐Yves Douillard, Gyula Ostoros, Manuel Cobo et al. · Journal of Thoracic Oncology · 2014 · 445 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines

Andreas Schlicker, Garry Beran, Christine M. Chresta et al. · BMC Medical Genomics · 2012 · 257 citations · Full text

Medicine, Cancer Biology, Oncology +17

A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples

Gillian Ellison, Emma Donald, Gael McWalter et al. · Journal of Experimental & Clinical Cancer Research · 2010 · 153 citations · Full text

Medicine, Genetics, Oncology +17

Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study

Gillian Ellison, Maria Orr, Karin Kemsley et al. · British Journal of Cancer · 2009 · 101 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Impact of KRAS codon subtypes from a randomised phase II trial of selumetinib plus docetaxel in KRAS mutant advanced non-small-cell lung cancer

Pasi A. Jänne, Ian C. P. Smith, Gael McWalter et al. · British Journal of Cancer · 2015 · 75 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 8